echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > CDE publicly solicits opinions on M7 (R2) related ICH guidelines

    CDE publicly solicits opinions on M7 (R2) related ICH guidelines

    • Last Update: 2021-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On December 21, CDE issued an announcement stating that the ICH guideline "M7 (R2): Assessment and Control of Active DNA (Mutogenic) Impurities in Drugs to Limit Potential Carcinogenic Risks" is now in the third stage for comments


    See the attachment for the original text and Chinese translation of M7 (R2).


    If you have any comments from all walks of life, please send feedback to our center via e-mail before February 15, 2022


    Contact: Ma Lei, Zhou Zhixing

    Email: mal@cde.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.